CVE-2022-30515
CVE-2022-30515 is a medium-severity vulnerability in Zkteco Biotime with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-306.
Key facts
- Severity: Medium (CVSS 3.x base score 5.3)
- EPSS exploit prediction: 1% (52nd percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-306
- Affected product: Zkteco Biotime
- Published:
- Last modified:
Description
ZKTeco BioTime 8.5.4 is missing authentication on folders containing employee photos, allowing an attacker to view them through filename enumeration.
Frequently asked questions
- What is CVE-2022-30515?
- ZKTeco BioTime 8.5.4 is missing authentication on folders containing employee photos, allowing an attacker to view them through filename enumeration.
- How severe is CVE-2022-30515?
- CVE-2022-30515 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
- Is CVE-2022-30515 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (52nd percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-30515?
- CVE-2022-30515 primarily affects Zkteco Biotime. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2022-30515?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2022-30515 published?
- CVE-2022-30515 was published on 2022-11-08 and last updated on 2026-06-17.
References
Affected products (2)
- cpe:2.3:a:zkteco:biotime:8.5.4:*:*:*:*:*:*:*
- cpe:2.3:a:zkteco:biotime:8.5.5:*:*:*:*:*:*:*
More vulnerabilities in Zkteco Biotime
- CVE-2023-38951 — Critical (CVSS 9.8): ZKTeco BioTime 8.5.5 through 9.x before 9.0.1 (20240617.19506) allows authenticated attackers to create or overwrite…
- CVE-2023-51142 — High (CVSS 7.5): An issue in ZKTeco BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information.
- CVE-2023-38952 — High (CVSS 7.5): Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due…
- CVE-2023-38950 — High (CVSS 7.5): A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read…
- CVE-2023-38949 — High (CVSS 7.5): An issue in a hidden API in ZKTeco BioTime v8.5.5 allows unauthenticated attackers to arbitrarily reset the…
- CVE-2024-13966 — High (CVSS 7.3): ZKTeco BioTime allows unauthenticated attackers to enumerate usernames and log in as any user with a password unchanged…
All CVEs affecting Zkteco Biotime →
Other CWE-306 (Missing Authentication for Critical Function) vulnerabilities
- CVE-2026-63692 — Critical (CVSS 10.0): Dell Container Storage Modules, versions prior to 1.18.0, contain(s) a Missing Authentication for Critical Function…
- CVE-2026-63688 — Critical (CVSS 10.0): Dell Container Storage Modules (CSM), versions prior to v1.18.0, contains a Missing Authentication for Critical…
- CVE-2026-103956 — Critical (CVSS 10.0): Missing authentication for critical function in the authentication dependency in Loom for AWS before 1.6.1 allowed…
- CVE-2026-53988 — Critical (CVSS 10.0): Dockhand before 1.0.40 contains an authentication bypass vulnerability in its git webhook endpoints that allows…
- CVE-2026-85889 — Critical (CVSS 10.0): Missing authentication for critical function in Azure AI Foundry allows an unauthorized attacker to elevate privileges…
- CVE-2026-92808 — Critical (CVSS 10.0): A server-side request forgery (SSRF) vulnerability exists in the UnifiedLogin service of Altium Enterprise Server. An…
Browse all CWE-306 (Missing Authentication for Critical Function) vulnerabilities →